文献速递脑血管病外科神经重症

高龄低分级动脉瘤性蛛网膜下腔出血患者的长期结局

Long-Term Outcomes of Elderly Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage.
PubMed 文献 · World Neurosurg · 2020-09-16

本研究回顾性纳入2012年4月至2018年9月单中心收治的≥70岁、WFNS IV-V级动脉瘤性蛛网膜下腔出血并接受动脉瘤治疗的患者,评估3个月和12个月临床结局并分析预后因素。结果显示12个月良好结局比例较3个月增加;无迟发性脑缺血及每日钠水平平均绝对差值波动小是3个月和12个月良好神经结局的显著预测因素,无脑实质出血仅与3个月良好结局显著相关。结论提示不应仅因年龄将高龄重症蛛网膜下腔出血患者排除在手术治疗之外。

要点

  • 高龄(≥70岁)低分级aSAH患者12个月良好结局比例较3个月增加
  • 无迟发性脑缺血与钠水平波动小是3个月和12个月良好结局的独立预测因素
  • 无脑实质出血仅与3个月良好结局显著相关,不影响长期结局

核心结论

  • 无迟发性脑缺血和每日钠水平平均绝对差值波动小与高龄低分级aSAH患者12个月良好神经结局独立相关。
  • 脑实质出血似乎不影响长期结局。
  • 高龄重症蛛网膜下腔出血患者不应仅因年龄被排除在手术治疗之外。

研究设计与样本

  • 单中心回顾性研究,纳入2012年4月至2018年9月收治的≥70岁、WFNS IV-V级动脉瘤性蛛网膜下腔出血并接受动脉瘤治疗的患者。
  • 在3个月和12个月评估临床结局,采用单因素和多因素分析识别良好神经结局(mRS 0-3)的独立预后因素。

主要发现

  • 12个月良好结局(mRS 0-3)患者比例较3个月增加。
  • 无脑实质出血是3个月良好神经结局的显著预测因素(P = 0.03)。
  • 无迟发性脑缺血和每日钠水平平均绝对差值波动小是3个月和12个月良好神经结局的显著预测因素(P = 0.04和P = 0.03)。

关键数值与推荐

  • 良好神经结局定义为改良Rankin量表评分0-3。
  • 低分级定义为WFNS分级IV和V级。
  • 高龄定义为年龄至少70岁。

临床怎么用

  • 对≥70岁WFNS IV-V级aSAH患者,不应仅因年龄放弃手术和重症治疗。
  • 监测并管理迟发性脑缺血和血钠波动可能有助于改善长期神经结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Long-term outcomes after surgical treatment and intensive care have not been investigated in elderly patients with poor-grade aneurysmal subarachnoid hemorrhage (aSAH). This study aimed to analyze 12-month outcomes and prognostic factors of patients with poor-grade aSAH who were at least age 70 years. METHODS: We performed a single-center, retrospective study including poor-grade (World Federation of Neurological Societies [WFNS] grades IV and V) aSAH patients who were at least age 70 years, were admitted to our stroke center, and received aneurysmal treatment between April 2012 and September 2018. The clinical outcomes were evaluated at months 3 and 12. Univariate/multivariate analyses were performed to identify the independent prognostic factors of good neurologic outcomes (modified Rankin Scale score 0-3). These factors included sex, age, WFNS grade, Fisher group, delayed cerebral ischemia, aneurysm treatment, aneurysm size, aneurysm location, and blood examination data in the 14 days post subarachnoid hemorrhage. RESULTS: The proportion of patients with good outcomes (modified Rankin Scale score 0-3) was increased at 12 months compared with that at 3 months. No intracerebral hemorrhage was a significant predictor of good neurologic outcomes at 3 months (P = 0.03). The absence of delayed cerebral ischemia and small fluctuations in the average absolute daily difference from normal sodium levels were significant predictors of good neurologic outcomes at months 3 and 12 (P = 0.04 and P = 0.03, respectively). CONCLUSIONS: The absence of delayed cerebral ischemia and small fluctuations in the average absolute daily difference from the normal sodium levels were independently associated with good neurologic outcomes at 12 months in elderly patients. Intracerebral hemorrhage did not appear to affect long-term outcomes. These findings suggest that elderly patients with severe subarachnoid hemorrhage should not be excluded from receiving surgical treatment on the basis of their age alone.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Yoshikawa S, Kamide T, Kikkawa Y, et al. Long-Term Outcomes of Elderly Patients with Poor-Grade Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2020. PMID: 32949799. doi:10.1016/j.wneu.2020.09.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。